DIVISLAB — Divi's Laboratories Share News
0.000.00%
- IN₹3.04tn
- IN₹3.02tn
- IN₹105.60bn
India's pharma index climbs after bumper Fed rate cut
India's Divi's Labs hits near 3-year high on block deals
India's Divi's Labs rises on report of favourable US court ruling on top drug
India's Divi's Labs slides on risk of generic versions of top drug
India's Divi's Labs slips on slow margin recovery
Indian pharma stocks head for best week in more than two years
Brief: Divi's Labs Says Us-FDA Inspection Of Co's Unit-II Manufacturing Facility At Andhra Pradesh
India's Zomato, Jio Financial likely to enter Nifty 50 in Sept, says Nuvama
Brief: NSE Circular - Divi's Laboratories And Trent Not Available For Trading In T+0 Rolling Settlement Cycle On June 24
India Stocks: Metal, pharma stocks drive Indian benchmarks higher
Indian benchmarks at record highs led by financials; volatility climbs
India's Divi's Labs rallies to 2-year high on healthy Q4 results
Snapshot: India stocks, rupee, swaps, call at 1:00 p.m. IST
Snapshot: India stocks, rupee, swaps, call at 1:00 p.m. IST
Brief: Divi's Laboratories In Process Of Entering Into A Long-Term Supply Agreement With A Customer
Indian shares flat after RBI's rate decision, but set for weekly gain
India's Divi's Labs set for best week in about 11 months
India's Divi's Labs gains on BofA's double upgrade to "buy"
India's Sun Pharma hits fourth all-time high this month